BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12704411)

  • 21. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
    Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
    Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
    Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
    Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodal promotes growth and invasion in human gliomas.
    Lee CC; Jan HJ; Lai JH; Ma HI; Hueng DY; Lee YC; Cheng YY; Liu LW; Wei HW; Lee HM
    Oncogene; 2010 May; 29(21):3110-23. PubMed ID: 20383200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution.
    Guedan S; Grases D; Rojas JJ; Gros A; Vilardell F; Vile R; Mercade E; Cascallo M; Alemany R
    Gene Ther; 2012 Nov; 19(11):1048-57. PubMed ID: 22113313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells.
    Nyormoi O; Mills L; Bar-Eli M
    Cell Death Differ; 2003 May; 10(5):558-69. PubMed ID: 12728254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.
    Kang CS; Zhang ZY; Jia ZF; Wang GX; Qiu MZ; Zhou HX; Yu SZ; Chang J; Jiang H; Pu PY
    Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
    You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat-directed tumor cell fusion.
    Brade AM; Szmitko P; Ngo D; Liu FF; Klamut HJ
    Hum Gene Ther; 2003 Mar; 14(5):447-61. PubMed ID: 12691610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
    Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
    Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.
    Bateman AR; Harrington KJ; Kottke T; Ahmed A; Melcher AA; Gough MJ; Linardakis E; Riddle D; Dietz A; Lohse CM; Strome S; Peterson T; Simari R; Vile RG
    Cancer Res; 2002 Nov; 62(22):6566-78. PubMed ID: 12438252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.
    Ahmed A; Jevremovic D; Suzuki K; Kottke T; Thompson J; Emery S; Harrington K; Bateman A; Vile R
    Gene Ther; 2003 Sep; 10(19):1663-71. PubMed ID: 12923565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
    Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells.
    Lim SH; Jeong YI; Moon KS; Ryu HH; Jin YH; Jin SG; Jung TY; Kim IY; Kang SS; Jung S
    Int J Pharm; 2010 Mar; 387(1-2):209-14. PubMed ID: 19945519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.
    Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I
    Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
    Jin SY; Jung YT
    Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.